Improving Risk Prediction for T1D Onset: Modeling and Assay Development for Clinical and Commercial Use

JDRF, the world’s leading non-profit organization with the mission to cure type 1 diabetes (T1D), invites Letters of Intent (LOI’s) for projects to improve risk prediction of T1D onset in two specific areas:

1) in silico modeling using existing genetic data to improve identification of the at-risk population

2) Integration of T1D Genetics or autoantibody testing into assay platforms that are commercially available as direct to consumer products or routinely used in clinical/public health laboratories

 

 

 

 

Funding: $300,000 per year

Duration: 2 years

 

 

 

 

Research Authority due date: 8.12.21

LOI (required) due date: 15.12.21

Full proposal due date: 16.2.21